Aronov; Alexander
Patent Applications and Registrations
Patent applications and USPTO patent grants for Aronov; Alexander.The latest application filed is for "crystalline forms of c21h22cl2n4o2".
- Aronov; Alexander - Newton MA
- Aronov; Alexander - Watertown MA
| Patent | Date |
|---|---|
| Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 11,390,600 - DeCrescenzo , et al. July 19, 2 | 2022-07-19 |
| CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20200339531 - DeCrescenzo; Gary ; et al. | 2020-10-29 |
| Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 10,738,027 - DeCrescenzo , et al. A | 2020-08-11 |
| CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20190127348 - DeCrescenzo; Gary ; et al. | 2019-05-02 |
| Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 10,183,927 - DeCrescenzo , et al. Ja | 2019-01-22 |
| CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20170320851 - DeCrescenzo; Gary ; et al. | 2017-11-09 |
| Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Grant 9,676,746 - DeCrescenzo , et al. June 13, 2 | 2017-06-13 |
| CRYSTALLINE FORMS OF C21H22Cl2N4O2 App 20160221987 - DeCrescenzo; Gary ; et al. | 2016-08-04 |
| Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases Grant 8,580,802 - Salituro , et al. November 12, 2 | 2013-11-12 |
| Heterocyclic inhibitors of c-Met and uses thereof Grant 8,481,538 - Aronov , et al. July 9, 2 | 2013-07-09 |
| c-MET protein kinase inhibitors Grant 8,232,406 - Lauffer , et al. July 31, 2 | 2012-07-31 |
| Inhibitors Of Phosphatidylinositol 3-kinase App 20110135603 - Wang; Tiansheng ; et al. | 2011-06-09 |
| C-met Protein Kinase Inhibitors App 20110059936 - Lauffer; David J. ; et al. | 2011-03-10 |
| c-MET protein kinase inhibitors Grant 7,872,031 - Lauffer , et al. January 18, 2 | 2011-01-18 |
| Inhibitors Of C-met And Uses Thereof App 20100190774 - Lauffer; David J. ; et al. | 2010-07-29 |
| Heterocyclic Inhibitors Of C-met And Uses Thereof App 20100144739 - Aronov; Alexander ; et al. | 2010-06-10 |
| Inhibitors of c-Met and uses thereof Grant 7,728,017 - Lauffer , et al. June 1, 2 | 2010-06-01 |
| Selective inhibitors of ERK protein kinase and uses thereof Grant 7,501,415 - Aronov , et al. March 10, 2 | 2009-03-10 |
| Heterocyclic inhibitors of ERK2 and uses thereof Grant 7,345,054 - Hale , et al. March 18, 2 | 2008-03-18 |
| Heterocyclic inhibitors of ERK2 and uses thereof Grant 7,304,061 - Hale , et al. December 4, 2 | 2007-12-04 |
| C-MET protein kinase inhibitors App 20070254868 - Lauffer; David J. ; et al. | 2007-11-01 |
| Deazapurines useful as inhibitors of Janus kinases App 20070207995 - Salituro; Francesco ; et al. | 2007-09-06 |
| Inhibitors of c-Met and uses thereof App 20070191369 - Lauffer; David J. ; et al. | 2007-08-16 |
| Selective inhibitors of ERK protein kinase and uses thereof App 20060160807 - Aronov; Alexander ; et al. | 2006-07-20 |
| Heterocyclic inhibitors of ERK2 and uses thereof App 20050234059 - Hale, Michael Robin ; et al. | 2005-10-20 |
| Heterocyclic inhibitors of ERK2 and uses thereof App 20040029857 - Hale, Michael Robin ; et al. | 2004-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 